Population density is beneficially associated with 12-year diabetes risk marker change among residents of lower socio-economic neighborhoods.


Journal

Health & place
ISSN: 1873-2054
Titre abrégé: Health Place
Pays: England
ID NLM: 9510067

Informations de publication

Date de publication:
05 2019
Historique:
received: 11 10 2018
revised: 07 02 2019
accepted: 11 02 2019
pubmed: 20 4 2019
medline: 15 9 2020
entrez: 20 4 2019
Statut: ppublish

Résumé

We examined associations of neighborhood population density with 12-year changes in diabetes risk (post-challenge plasma glucose), and potential moderation by neighborhood socio-economic status (SES) among 4,816 Australians. In lower SES neighborhoods, post-challenge plasma glucose increased by 6% in low-density, remained stable in medium-density and decreased by 3% in high-density neighborhoods. In medium SES neighborhoods, glucose remained stable in high-density, but increased by 2% and 3% in medium- and low-density neighborhoods, respectively. In higher SES neighborhoods, no significant interaction effect between time and density was observed. Densification may make protective contributions for diabetes risk in lower and medium SES neighborhoods.

Identifiants

pubmed: 31003191
pii: S1353-8292(18)31026-8
doi: 10.1016/j.healthplace.2019.02.006
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

74-81

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Jelle Van Cauwenberg (J)

Department of Public Health, Ghent University, De Pintelaan 185, 9000 Ghent, Belgium; Research Foundation Flanders, Egmontstraat 5, 1000 Brussels, Belgium. Electronic address: Jelle.vancauwenberg@ugent.be.

David Dunstan (D)

Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia; Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, VIC 3000, Australia.

Ester Cerin (E)

Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia; Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, VIC 3000, Australia; School of Public Health, The University of Hong Kong, 7 Sassoon Road, Pokfulam, Hong Kong, China.

Mohammad Javad Koohsari (MJ)

Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia; Faculty of Sport Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa, Saitama 359-1192, Japan.

Takemi Sugiyama (T)

Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia; Mary MacKillop Institute for Health Research, Australian Catholic University, Level 5, 215 Spring Street, Melbourne, VIC 3000, Australia; Faculty of Sport Sciences, Waseda University, 2-579-15 Mikajima, Tokorozawa, Saitama 359-1192, Japan.

Neville Owen (N)

Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia; Swinburne University of Technology, John Street, Hawthorne, VIC 3122, Hawthorn, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH